1. Market Research
  2. > Pharmaceutical Market Trends
GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET FORECAST 2021-2028

GLOBAL PHARMACEUTICAL CONTINUOUS MANUFACTURING MARKET FORECAST 2021-2028

  • February 2021
  • 205 pages
  • ID: 5882048
  • Format: PDF
  • Inkwood Research

Summary

Table of Contents

KEY FINDINGS
The global pharmaceutical continuous manufacturing market is anticipated to register a CAGR of 10.23%, during the studied period of 2021 to 2028. The market growth is facilitated by key drivers, such as, the increasing adoption of pharmaceutical continuous manufacturing systems, the government initiatives for adopting continuous manufacturing systems, the opportunities for development across emerging markets, the rising production of large molecules and biologics, and the increasing healthcare expenditure.

MARKET INSIGHTS
Continuous manufacturing entails an advanced manufacturing approach conducted by employing end-to-end integration of manufacturing subprocesses, along with a substantial level of control strategies.
The growth of the global pharmaceutical continuous manufacturing market is anticipated to be fueled by the opportunities across the untapped and emerging markets, owing to the availability of enhanced pharmaceutical infrastructure, the increased demand for pharmaceutical continuous manufacturing systems, and the growing number of pharmaceutical industries. Moreover, emerging countries’ healthcare industry is also augmenting at a considerable rate, given the increased demand for advanced manufacturing systems, as well as notable government investments, in order to improve the healthcare infrastructure.

REGIONAL INSIGHTS
The global pharmaceutical continuous manufacturing market growth is evaluated by studying the Asia Pacific, North America, Europe, and the rest of the Asia Pacific. The Asia Pacific is anticipated to grow with the highest CAGR over the forecast period, owing to factors such as, the augmenting contract research organization (CRO) and contract manufacturing organization (CMO), and growing investments across the region’s pharmaceutical and biopharmaceutical industry.

COMPETITIVE INSIGHTS
Although the industry growth of the pharmaceutical continuous manufacturing market is high, the product differentiation is considerably low.Besides, key players are reluctant to divest from their businesses.

With a substantial amount of investment involved, the exit barriers are moderately difficult. As a result, the degree of competitive rivalry is projected as moderate to high, over the forecast period.
Some of the key players operating in the market are, Korsch AG, Pfizer Inc, Eli Lilly & Company, Siemens Healthineers, Thermo Fisher Scientific Inc, etc.

Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation cater to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

Companies mentioned
1. COPERION GMBH
2. ELI LILLY & COMPANY
3. GEA GROUP AG
4. GEBRUDER LODIGE MASCHINENBAU GMBH
5. GLATT GMBH
6. HOSOKAWA MICRON CORPORATION
7. KORSCH AG
8. LB BOHLE MASCHINEN + VERFAHREN GMBH
9. MUNSON MACHINERY COMPANY
10. PFIZER INC
11. SIEMENS HEALTHINEERS
12. SYNTEGON (FORMERLY BOSCH PACKAGING TECHNOLOGY)
13. THERMO FISHER SCIENTIFIC INC

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021-2026)

  • $ 4250
  • March 2021
  • 342 pages

The Global Pharmaceutical CDMO Market was valued USD 160.12 billion in 2020, and it is expected to reach USD 236.61 billion by 2026, registering a CAGR of 6.5%, during the period of forecast period (2021-2026). ...

  • World
  • Europe
  • Pharmaceutical
  • Industry analysis
  • Pharmaceutical Production
  • Health Expenditure

Global D-Amino Acids Industry $ 5600 April 2021

Global Ionic Liquids Industry $ 4950 April 2021


ref:plp2021

Reportlinker.com © Copyright 2021. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on